Skip to content
OpenCapital
Get started

Definitive Healthcare Corp. DH R&D

R&D at other companies

Microsoft logo
MicrosoftMSFT
$8.92B+8.7%
Veeva Systems logo
Veeva SystemsVEEV
$208.32M+13.2%
Health Catalyst logo
Health CatalystHCAT
$9.78M-35.6%
Teladoc Health logo
Teladoc HealthTDOC
$67.87M-3.0%
SS&C Technologies logo
SS&C TechnologiesSSNC
$134.6M+4.3%
Intuitive Surgical logo
Intuitive SurgicalISRG
$361.9M+14.5%

Other financials

Income statement

See full
Revenue$55.9M-5.5%
Gross profit$46.6M-5.0%
Operating income-$201.3M-8.9%
Net income-$138.6M-29.3%
EPS (diluted)-$1.32-38.9%

Balance sheet

See full
Cash & equivalents$157.6M+48.6%
Total debt$169.8M-6.0%
Total assets$514.7M-36.3%

Cash flow

See full
Operating cash flow$11.6M-55.6%
CapEx$3.2M-58.4%
Free cash flow$8.4M-54.5%

Valuation

See full
Market cap$87.68M-79.8%
Enterprise value$99.87M-81.2%
P/S0.4×-1.4×

Profitability

See full
Gross margin84.4%+1.0pp
Operating margin-101.1%-42.1pp
Net margin-71.5%-28.2pp
FCF margin12.1%-8.4pp

Returns & leverage

See full
Current ratio1.8×0.0×

Where this comes from

Reported directly by Definitive Healthcare Corp. in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Definitive Healthcare Corp.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Definitive Healthcare Corp.'s r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Definitive Healthcare Corp.'s R&D?
Definitive Healthcare Corp. (DH) reported R&D of $6.5M in Q1 2026.
How has Definitive Healthcare Corp.'s R&D changed year-over-year?
Definitive Healthcare Corp.'s R&D decreased by 30.1% year-over-year, from $9.3M to $6.5M.
What is the long-term trend for Definitive Healthcare Corp.'s R&D?
Over 4 years (2021 to 2025), Definitive Healthcare Corp.'s R&D has grown at a 17.0% compound annual growth rate (CAGR), from $18.57M to $34.78M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.